Paper Details

  1. Home
  2. Paper Details

Long-term statin safety and efficacy in secondary prevention: can combination therapy improve outcomes?

Author: WascherThomas C

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.

Overview

Statins have been shown to significantly reduce the risk of heart disease and death. The Prospective Pravastatin Pooling Project (PPP) showed that pravastatin reduced total mortality and had similar rates of muscle side effects as placebo. Combining statins with aspirin appears to provide even greater heart disease risk reduction compared to either medication alone. Statins are effective in preventing further heart problems and death in people with existing heart disease or high risk, and are safe.
Paper Details　
Original Abstract of the Article :
The use of statins has been associated with substantial reductions in vascular morbidity and mortality. The Prospective Pravastatin Pooling Project (PPP) looked at the long-term safety and efficacy of statins in secondary prevention, based on pooled results from three key statin trials. PPP revealed...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s1567-5688(03)90002-x

データ提供：米国国立医学図書館（NLM）

Statins: A Lifeline in the Desert of Cardiovascular Disease

Cardiovascular disease, a leading cause of death and disability worldwide, is a vast and complex challenge. This research explores the role of statins, medications that lower cholesterol levels, in secondary prevention of cardiovascular events. The authors investigated the long-term safety and efficacy of statins in patients with a history of cardiovascular disease, like a team of explorers seeking to navigate a treacherous desert landscape.

Statins: A Powerful Tool in Cardiovascular Prevention

The study revealed that statins significantly reduced the risk of further cardiovascular events and mortality in patients with a history of cardiovascular disease. Think of these medications as powerful tools that can help to prevent the harsh desert storms of cardiovascular complications. The authors also observed that statins demonstrated a similar incidence of muscle-related side effects as placebo, suggesting a favorable safety profile.

Combination Therapy: A Strategic Approach

The study emphasizes the potential benefits of combining statins with other cardiovascular medications, such as aspirin. This combination therapy approach may offer synergistic effects, further reducing the risk of cardiovascular events. It's like combining different resources in a desert to create a more resilient oasis.

Dr. Camel's Conclusion

This research provides a robust foundation for the use of statins in secondary cardiovascular prevention. It highlights the significant benefits of statins in reducing cardiovascular risk and underscores the potential for even greater effectiveness when combined with other medications. As we continue to explore the vast desert of cardiovascular health, statins offer a valuable tool for preventing the storms of disease and promoting a healthier future.
Date :
  1. Date Completed 2004-03-09
  2. Date Revised 2019-11-08
Further Info :

Pubmed ID

14980230

DOI: Digital Object Identifier

10.1016/s1567-5688(03)90002-x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.